543 related articles for article (PubMed ID: 28605026)
1. What's in a name? Atopic dermatitis or atopic eczema, but not eczema alone.
Silverberg JI; Thyssen JP; Paller AS; Drucker AM; Wollenberg A; Lee KH; Kabashima K; Todd G; Schmid-Grendelmeier P; Bieber T
Allergy; 2017 Dec; 72(12):2026-2030. PubMed ID: 28605026
[TBL] [Abstract][Full Text] [Related]
2. Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of 'atopic dermatitis'.
Kantor R; Thyssen JP; Paller AS; Silverberg JI
Allergy; 2016 Oct; 71(10):1480-5. PubMed ID: 27392131
[TBL] [Abstract][Full Text] [Related]
3. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment.
Lloyd-Lavery A; Solman L; Grindlay DJC; Rogers NK; Thomas KS; Harman KE
Clin Exp Dermatol; 2019 Jun; 44(4):376-380. PubMed ID: 30706507
[TBL] [Abstract][Full Text] [Related]
4. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Vermeulen FM; Gerbens LAA; Bosma AL; Apfelbacher CJ; Irvine AD; Arents BWM; Barbarot S; Deleuran M; Eichenfield LF; Manca A; Schmitt J; Vestergaard C; Wall D; Weidinger S; Middelkamp-Hup MA; Spuls PI; Flohr C;
Br J Dermatol; 2019 Sep; 181(3):492-504. PubMed ID: 30719709
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council.
Eichenfield LF; Kusari A; Han AM; Barbarot S; Deleuran M; Lio P; Marcoux D; Nosbaum A; Stalder JF
JAAD Int; 2021 Jun; 3():8-13. PubMed ID: 34409365
[TBL] [Abstract][Full Text] [Related]
6. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
[TBL] [Abstract][Full Text] [Related]
7. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
[TBL] [Abstract][Full Text] [Related]
8. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.
Gerbens LA; Prinsen CA; Chalmers JR; Drucker AM; von Kobyletzki LB; Limpens J; Nankervis H; Svensson Å; Terwee CB; Zhang J; Apfelbacher CJ; Spuls PI;
Allergy; 2017 Jan; 72(1):146-163. PubMed ID: 27322918
[TBL] [Abstract][Full Text] [Related]
10. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion.
Thyssen JP; de Bruin-Weller MS; Paller AS; Leshem YA; Vestergaard C; Deleuran M; Drucker AM; Foelster-Holst R; Traidl-Hoffmann C; Eyerich K; Taieb A; Su JC; Bieber T; Cork MJ; Eichenfield LF; Guttman-Yassky E; Wollenberg A
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1224-1231. PubMed ID: 31056788
[TBL] [Abstract][Full Text] [Related]
11. Eczema, Atopic Dermatitis, or Atopic Eczema: Analysis of Global Search Engine Trends.
Xu S; Thyssen JP; Paller AS; Silverberg JI
Dermatitis; 2017; 28(4):276-279. PubMed ID: 28722692
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis.
Liu P; Zhao Y; Mu ZL; Lu QJ; Zhang L; Yao X; Zheng M; Tang YW; Lu XX; Xia XJ; Lin YK; Li YZ; Tu CX; Yao ZR; Xu JH; Li W; Lai W; Yang HM; Xie HF; Han XP; Xie ZQ; Nong X; Guo ZP; Deng DQ; Shi TX; Zhang JZ
Chin Med J (Engl); 2016 Apr; 129(7):757-62. PubMed ID: 26996468
[TBL] [Abstract][Full Text] [Related]
13. Atopic eczema: what's new?
Möhrenschlager M; Darsow U; Schnopp C; Ring J
J Eur Acad Dermatol Venereol; 2006 May; 20(5):503-11, 513; quiz 512. PubMed ID: 16684275
[TBL] [Abstract][Full Text] [Related]
14. Atopic dermatitis or eczema? Consequences of ambiguity in disease name for biomedical literature mining.
Frainay C; Pitarch Y; Filippi S; Evangelou M; Custovic A
Clin Exp Allergy; 2021 Sep; 51(9):1185-1194. PubMed ID: 34213816
[TBL] [Abstract][Full Text] [Related]
15. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E
Br J Dermatol; 2018 Mar; 178(3):768-775. PubMed ID: 28865094
[TBL] [Abstract][Full Text] [Related]
16. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS; Apfelbacher CA; Chalmers JR; Simpson E; Spuls PI; Gerbens LAA; Williams HC; Schmitt J; Gabes M; Howells L; Stuart BL; Grinich E; Pawlitschek T; Burton T; Howie L; Gadkari A; Eckert L; Ebata T; Boers M; Saeki H; Nakahara T; Katoh N
Br J Dermatol; 2021 Jul; 185(1):139-146. PubMed ID: 33393074
[TBL] [Abstract][Full Text] [Related]
17. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
Simpson E; Bissonnette R; Eichenfield LF; Guttman-Yassky E; King B; Silverberg JI; Beck LA; Bieber T; Reich K; Kabashima K; Seyger M; Siegfried E; Stingl G; Feldman SR; Menter A; van de Kerkhof P; Yosipovitch G; Paul C; Martel P; Dubost-Brama A; Armstrong J; Chavda R; Frey S; Joubert Y; Milutinovic M; Parneix A; Teixeira HD; Lin CY; Sun L; Klekotka P; Nickoloff B; Dutronc Y; Mallbris L; Janes JM; DeLozier AM; Nunes FP; Paller AS
J Am Acad Dermatol; 2020 Sep; 83(3):839-846. PubMed ID: 32344071
[TBL] [Abstract][Full Text] [Related]
18. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomes.
Hatfield SJ; Rogers NK; Lloyd-Lavery A; Grindlay D; Barnett R; Thomas KS
Clin Exp Dermatol; 2016 Dec; 41(8):843-846. PubMed ID: 27805275
[TBL] [Abstract][Full Text] [Related]
19. Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus.
Abuabara K; Nicholls SG; Langan SM; Guttman-Yassky E; Reynolds NJ; Paller AS; Brown SJ;
Br J Dermatol; 2021 Jul; 185(1):203-205. PubMed ID: 33570761
[No Abstract] [Full Text] [Related]
20. Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination.
Naleway AL; Belongia EA; Greenlee RT; Kieke BA; Chen RT; Shay DK
Ann Intern Med; 2003 Jul; 139(1):1-7. PubMed ID: 12834312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
